Sandalwood giant can smell big dollars in warts more

ViroXis Corporation Announces expanded board of directors and advisors more

ITClamp Hemorrhage Control System from Innovative Trauma Care more

ViroXis Corporation Initiates Phase II Clinical Trial of Novel Botanical Topical Treatment for HPV Skin Warts more

Vidacare Corp. aims to ease that pain with the OnControl Bone Marrow System. The Bronze winner of The Wall Street Journal's Technology Innovation Awards, and winner of the Medical-Devices category, the product allows doctors to more quickly and precisely take samples from inside the bone more

DNAtrix, Inc., the Houston-based biotechnology company developing targeted adenovirus-based oncolytic virus products, announced today a merger with VectorLogics, Inc. more

Innovative Trauma Care (ITC) has received regulatory approval from Health Canada for commercial sale of its first product, the IT Clamp™ more

BiO2 Medical, Inc and R&D and manufacturing operations in Golden, Colorado, has recently secured $12M in Series C funding more

SAN ANTONIO, Sept. 6, 2012 -- /PRNewswire/ -- ENTrigue Surgical, Inc. ("ENTrigue"), a San Antonio, Texas-based company that designs, develops, manufactures and distributes medical devices used for Ear, Nose and Throat surgical procedures, announced today a collaboration agreement with fiagon GmbH, a company based in Berlin, Germany, that develops and manufactures a new generation of intelligent and highly portable navigation systems for ENT, oral and maxillofacial surgery and neurosurgery. As part of their collaboration, ENTrigue and fiagon will explore the delivery of integrated navigation and therapy solutions for ENT procedures starting with ENTrigue's Ventera® Sinus Dilation System in Europe.

Dr. Timo Kruger, fiagon CEO, commented, "The team at fiagon is excited to be working with the experienced ENT industry professionals at ENTrigue. We are encouraged by the possibilities."

The ENTrigue Ventera® Sinus Dilation System includes a single-use balloon delivered by one of several reusable instruments utilizing ENTrigue's proprietary SerpENT® articulating technology and does not require either manual tip shaping or the use of a guide wire or cannula to deliver the balloon into various sinuses. The Ventera® Sinus Dilation System is the only balloon system that can be inserted transnasally and then articulated in-place to best access any sinus cavity. The combination of real-time navigation with balloon dilation is expected to significantly enhance the capability of ENT surgeons to perform minimally invasive sinus surgery.

Fred Dinger, ENTrigue CEO, added, "Integrating fiagon's navigation to our sinus dilation platform will provide the ENT surgeon with an unparalleled level of confirmation of balloon position within the sinus anatomy. We look forward to collaborating with fiagon to combine two game-changing platforms with the goal of bringing easy-to-use, cost effective technologies to the sinus surgery market."

ENTrigue's Ventera® Sinus Dilation System with fiagon's Dynamic Navigation System will be on display in ENTrigue's booth at the upcoming American Academy of Otolaryngology-Head and Neck Surgery meeting in Washington, DC. The Ventera® Sinus Dilation System is presently available in only a limited number of countries in Europe and Canada and is not available for sale in the United States. The Dynamic Navigation System from fiagon is currently available in certain countries in Europe.

fiagon develops and manufactures a new generation of intelligent and highly portable navigation systems for ENT, oral and maxillofacial surgery and neurosurgery. The fiagon navigation system uses electromagnetic tracking matrix algorithms and unique flexible pointing devices to simplify the use of modern navigation and diagnostic tools in daily clinical routine.

For more information about ENTrigue Surgical, Inc., please visit www.entriguesurgical.com or contact customerservice@entriguesurgical.com.

For more information about fiagon GmbH, please visit www.fiagon.de back

Soluble Therapeutics, Inc. Awarded ~$1MM NIH Grant for Continued Development of the HSC Technology for Protein Formulation more

Vidacare Corporation Creates New Medical Director of Clinical Affairs Position for Intraosseous Vascular Access Division more

BiO2 Medical Granted CE Mark for the Angel™ Catheter, the First IVC Filter with a Prophylactic Use Indication more

NMP Neuwirth Medical Products GmbH signs an exclusive distribution partnership for the Ventera, MediENT, ENTact, Synaero, and SerpENT in Germany

ENTrigue Surgical participates in the first Global Update on FESS, The Sinuses, and The Nose in Vienna, Austria

BiO2 Medical Announces First in Man Clinical Study more

BiO2 Medical Secures Series B Round Funding more

Study Finds Intraosseous Infusion is Equivalent to Intravenous Infusion During Therapeutic Hypothermia more

Vidacare Corporation to Sponsor 2012 British Journal of Nursing Haematology Award Category more